NVDA
NVIDIA
-- 128.910 TSLA
Tesla
-- 440.130 MU
Micron Technology
-- 103.900 QUBT
Quantum Computing
-- 25.680 PLTR
Palantir
-- 71.510 
NEWS
Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics (NYSE: SER) has announced a upcoming webinar presentation focused on continuous drug delivery solutions for Parkinson's disease. The event, titled 'Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond,' will feature CEO Steven A. Ledger and is scheduled for December 18, 2024, at 8:30 AM Pacific/11:30 AM Eastern.
The presentation will address continuous dopaminergic stimulation (CDS), which has demonstrated effectiveness in reducing motor complications in advanced Parkinson's patients. The discussion will compare Serina's IND candidate's target product profile with current standard treatments in providing CDS. The event will be hosted by Tribe Public's Managing Member John F. Heerdink, Jr., and will include a Q&A session.
Serina Therapeutics (NYSE: SER) has announced a upcoming webinar presentation focused on continuous drug delivery solutions for Parkinson's disease. The event, titled 'Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond,' will feature CEO Steven A. Ledger and is scheduled for December 18, 2024, at 8:30 AM Pacific/11:30 AM Eastern.
The presentation will address continuous dopaminergic stimulation (CDS), which has demonstrated effectiveness in reducing motor complications in advanced Parkinson's patients. The discussion will compare Serina's IND candidate's target product profile with current standard treatments in providing CDS. The event will be hosted by Tribe Public's Managing Member John F. Heerdink, Jr., and will include a Q&A session.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment